ALXO - CIK 0001810182
The table below shows ALX ONCOLOGY HOLDINGS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $16.37M | $17.57M | $22.41M | $48.82M | $363.67M | $434.22M |
| Short-term investments | $28.42M | $110.19M | $160.33M | $217.38M | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $50.73M |
| $134.35M |
| $188.66M |
| $270.97M |
| $367.02M |
| $435.99M |
| Property, plant & equipment | $1.20M | $2.90M | $3.59M | $3.89M | $897.00K | $52.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $59.05M | $147.78M | $242.55M | $306.49M | $380.18M | $436.05M |
| Accounts payable | $4.91M | $4.50M | $8.59M | $8.07M | $3.76M | $4.00K |
| Total current liabilities | $24.55M | $18.50M | $36.00M | $28.32M | $15.29M | $6.20M |
| Long-term debt | $4.53M | $9.47M | $9.64M | $9.39M | - | $5.42M |
| Total liabilities | $33.06M | $34.16M | $52.84M | $43.02M | $17.13M | $6.21M |
| Retained earnings | -$722.82M | -$621.12M | -$486.27M | -$325.47M | -$201.99M | -$118.52M |
| Total equity | $25.98M | $113.62M | $189.71M | $263.46M | $363.05M | $429.85M |